MNPR – monopar therapeutics inc. (US:NASDAQ)
Stock Stats
News
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its price target raised by analysts at HC Wainwright from $6.00 to $22.00. They now have a "buy" rating on the stock.
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock [Yahoo! Finance]
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
Form 8-K Monopar Therapeutics For: Nov 08
Form 10-Q Monopar Therapeutics For: Sep 30
Form SC 13G Monopar Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Form SC 13G Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 4 Monopar Therapeutics For: Oct 28 Filed by: Radhakrishnan Karthik
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.